Towards Healthcare Research & Consulting
Liver Cancer Drugs Market
Updated Date: 06 July 2026   |   Report Code: 5146
[email protected] +1 804-441-9344
Download Sample Order Now

Liver Cancer Drugs Market Size Innovations, Trends and Opportunities 2026

According to market projections, the global liver cancer drugs market, valued at USD 3.97 billion in 2026, is anticipated to reach USD 13.13  billion by 2035, growing at a CAGR of 14.2% over the next decade. Liver cancer drugs are medicines used to treat liver cancer by stopping cancer cell growth, shrinking tumors, or boosting the immune system to fight the disease. They include targeted therapies, immunotherapies, chemotherapy, and newer treatments that improve survival and quality of life.

Last Updated : 06 July 2026 Category: Therapeutic Area Insight Code: 5146 Format: PDF / PPT / Excel

Content

Introduction

  • Research Objective
  • Scope of the Study
  • Definition and Taxonomy

Research Methodology

  • Research Approach
  • Data Sources
  • Assumptions

Executive Summary

  • Synopsis
  • Analyst Recommendations

Market Overview 

  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Value Chain Analysis
    • Raw Material Sourcing
    • Manufacturing Process
    • Logistics & Transportation
    • Buyer Preferences
  • Trends
    • Market Trends
    • Technological Trends
  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers
    • Bargaining Power of Buyers
    • Threat of Substitute
    • Threat of New Entrants
    • Degree of Competition
  • PESTLE Analysis for 5 Leading Countries
    • Regulatory Framework for Leading Countries/Regions
    • Supply Demand Analysis
    • Production & Consumption Statistics
    • Export Import Statistics
    • Price Trend Analysis

Global Liver Cancer Drugs Market Assessment

  • Overview
  • Global Liver Cancer Drugs Market Size Value (US$) and Volume (Billion Tons), by Drug Class (2021 – 2033)
    • Targeted Therapy 
      • Bevacizumab
      • Cabozantinib
      • Lenvatinib
      • Ramucirumab
      • Regorafenib
      • Sorafenib
      • Other Targeted Therapies
    • Immunotherapy 
      • Atezolizumab with Bevacizumab
      • Nivolumab with Ipilimumab
      • Pembrolizumab
      • Durvalumab with Tremelimumab
      • Other Immunotherapies
    • Chemotherapy 
      • Gemcitabine
      • Oxaliplatin
      • Cisplatin
      • Doxorubicin
      • 5-fluorouracil
      • Capecitabine
      • Mitoxantrone
      • Other Chemotherapies
  • Global Liver Cancer Drugs Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Pharmacy
  • Global Liver Cancer Drugs Market Size Value (US$) and Volume (Billion Tons), by Geography (2021 – 2033)
    • North America
    • Europe
    • Asia Pacific
    • Middle East and Africa
    • South America

North America Liver Cancer Drugs Market Assessment

  • Overview
  • North America Liver Cancer Drugs Market Size Value (US$) and Volume (Billion Tons), by Drug Class (2021 – 2033)
    • Targeted Therapy 
      • Bevacizumab
      • Cabozantinib
      • Lenvatinib
      • Ramucirumab
      • Regorafenib
      • Sorafenib
      • Other Targeted Therapies
    • Immunotherapy 
      • Atezolizumab with Bevacizumab
      • Nivolumab with Ipilimumab
      • Pembrolizumab
      • Durvalumab with Tremelimumab
      • Other Immunotherapies
    • Chemotherapy 
      • Gemcitabine
      • Oxaliplatin
      • Cisplatin
      • Doxorubicin
      • 5-fluorouracil
      • Capecitabine
      • Mitoxantrone
      • Other Chemotherapies
  • North America Liver Cancer Drugs Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Pharmacy

Europe Liver Cancer Drugs Market Assessment

  • Overview
  • Europe Liver Cancer Drugs Market Size Value (US$) and Volume (Billion Tons), by Drug Class (2021 – 2033)
    • Targeted Therapy 
      • Bevacizumab
      • Cabozantinib
      • Lenvatinib
      • Ramucirumab
      • Regorafenib
      • Sorafenib
      • Other Targeted Therapies
    • Immunotherapy 
      • Atezolizumab with Bevacizumab
      • Nivolumab with Ipilimumab
      • Pembrolizumab
      • Durvalumab with Tremelimumab
      • Other Immunotherapies
    • Chemotherapy 
      • Gemcitabine
      • Oxaliplatin
      • Cisplatin
      • Doxorubicin
      • 5-fluorouracil
      • Capecitabine
      • Mitoxantrone
      • Other Chemotherapies
  • Europe Liver Cancer Drugs Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Pharmacy

Asia Pacific Liver Cancer Drugs Market Assessment

  • Overview
  • Asia Pacific Liver Cancer Drugs Market Size Value (US$) and Volume (Billion Tons), by Drug Class (2021 – 2033)
    • Targeted Therapy 
      • Bevacizumab
      • Cabozantinib
      • Lenvatinib
      • Ramucirumab
      • Regorafenib
      • Sorafenib
      • Other Targeted Therapies
    • Immunotherapy 
      • Atezolizumab with Bevacizumab
      • Nivolumab with Ipilimumab
      • Pembrolizumab
      • Durvalumab with Tremelimumab
      • Other Immunotherapies
    • Chemotherapy 
      • Gemcitabine
      • Oxaliplatin
      • Cisplatin
      • Doxorubicin
      • 5-fluorouracil
      • Capecitabine
      • Mitoxantrone
      • Other Chemotherapies
  • Asia Pacific Liver Cancer Drugs Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Pharmacy

Middle East and Africa Liver Cancer Drugs Market Assessment

  • Overview
  • Middle East and Africa Liver Cancer Drugs Market Size Value (US$) and Volume (Billion Tons), by Drug Class (2021 – 2033)
    • Targeted Therapy 
      • Bevacizumab
      • Cabozantinib
      • Lenvatinib
      • Ramucirumab
      • Regorafenib
      • Sorafenib
      • Other Targeted Therapies
    • Immunotherapy 
      • Atezolizumab with Bevacizumab
      • Nivolumab with Ipilimumab
      • Pembrolizumab
      • Durvalumab with Tremelimumab
      • Other Immunotherapies
    • Chemotherapy 
      • Gemcitabine
      • Oxaliplatin
      • Cisplatin
      • Doxorubicin
      • 5-fluorouracil
      • Capecitabine
      • Mitoxantrone
      • Other Chemotherapies
  • Middle East and Africa Liver Cancer Drugs Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Pharmacy

South America Liver Cancer Drugs Market Assessment

  • Overview
  • South America Liver Cancer Drugs Market Size Value (US$) and Volume (Billion Tons), by Drug Class (2021 – 2033)
    • Targeted Therapy 
      • Bevacizumab
      • Cabozantinib
      • Lenvatinib
      • Ramucirumab
      • Regorafenib
      • Sorafenib
      • Other Targeted Therapies
    • Immunotherapy 
      • Atezolizumab with Bevacizumab
      • Nivolumab with Ipilimumab
      • Pembrolizumab
      • Durvalumab with Tremelimumab
      • Other Immunotherapies
    • Chemotherapy 
      • Gemcitabine
      • Oxaliplatin
      • Cisplatin
      • Doxorubicin
      • 5-fluorouracil
      • Capecitabine
      • Mitoxantrone
      • Other Chemotherapies
  • South America Liver Cancer Drugs Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Pharmacy

Company Profiles

  • Bayer AG
    • Company Overview
    • Geographic Footprints
    • Financial Performance
    • Product Portfolio
    • SWOT Analysis
    • R&D Efforts
    • Recent Developments & Strategic Collaborations
      • Product Launch/M&A/Technical Collaboration
  • Bristol-Myers Squibb Company
  • Eisai Co., Ltd.
  • Exelixis, Inc.
  • Merck KGaA
  • Pfizer Inc.
  • Eisai Inc.
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd.

Conclusion & Recommendations

FAQ's

Answer : The global liver cancer drugs market is projected to grow from USD 3.97 billion in 2026 to approximately USD 13.13 billion by 2035, registering a CAGR of 14.2%.

Answer : Despite recent progress, liver cancer treatment still needs a great deal of improvement. These unfulfilled needs include: improved medications for advanced hepatic carcinoma decreased adverse effects and increased efficacy, early identification, and diagnosis.

Answer : Global Cancer Observatory, American Liver Foundation, World Health Organization, National Institute of Health.
Any Questions

Meet the Team

Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare market research. As a content reviewer, Aditi ensures the quality and accuracy of all market insights and data presented by the research team.

Learn more about Aditi Shivarkar